Zinzino: ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q3 2020

Strong sales growth during Q3; Zinzino group revenue increased with a total of 49% in Q3 and 49% YTD, compared with the previous year.

The revenue in September for Zinzino's sales markets increased by 64% to SEK 98.1 (60.0) million primarily due to strong growth foremost in Central Europe. Faun Pharma's external sales increased by 32% and amounted to SEK 5.4 (4.1) million. Overall, the Group increased revenues by 61% to SEK 103.5 (64.1) million compared with the previous year.

The third quarter of 2020 became the strongest quarter in the history of the company. The Zinzino based revenue in July - September increased 52% SEK 265.4 (174.9) million compared with previous year. Total group revenue increased 49% to SEK 278,2 (186,5) million.

Accumulated revenue for January - September 2020 increased by 49% SEK 794.6 (534.3) million.

Revenues distributed as follows:
   

Regions,MSEK 20 19 Change Q3 Q3 Change YTD YTD Change
-sep -sep 2020 2019 2020 2019
Nordic 34.5 28.9 19% 96.6 88.3 9% 288.8 277.0 4%
Markets
Europe Other 50.5 23.4 116% 137.3 65.6 109% 372.1 162.3 129%
Markets
Baltic 5.5 4.2 31% 15.4 12.3 25% 48.8 38.3 27%
Markets
North 4.1 1.8 128% 10.1 5.4 87% 27.0 16.1 68%
America
Australia 3.5 1.7 106% 6.0 3.3 81% 15.7 4.8 227%
Zinzino 98.1 60.0 64% 265.4 174.9 52% 752.4 498.5 51%
Faun Pharma 5.4 4.1 32% 12.8 11.6 10% 42.2 35.8 18%
Zinzino 103.5 64.1 61% 278.2 186.5 49% 794.6 534.3 49%
Group

  
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge:
Marcus Tollbom +46 (0) 70 190 03 12, marcus.tollbom@zinzino.com

Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se

Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 15:30 the 5th of October 2020.

   
Zinzino AB (publ.) is a global Direct Sales company that markets and sells test-based nutrition, skincare and life-style products. Zinzino owns the research unit BioActive Foods AS and production unit Faun Pharma AS. Zinzino is based in Gothenburg, with additional offices in Finland, Latvia, Norway, USA, Australia and Hong Kong. Zinzino is a public company and its shares are listed on Nasdaq First North Premier Growth Market.

Source: Cision
Tillbaka

Det verkar som att du använder en annonsblockerare

Om du är prenumerant behöver du logga in för att fortsätta. Vill bli prenumerant kan du läsa Di Digitalt för 197 kr inkl. moms de första 3 månaderna.

  • Full tillgång till di.se med nyheter och analyser

  • Tillgång till över 1100 aktiekurser i realtid

  • Innehållet i alla Di:s appar, tjänster och nyhetsbrev

3 månader för
197 kr
Spara 1000 kr

Prenumerera

Redan prenumerant?